Suppr超能文献

阳性淋巴结检出率可优化结直肠癌患者的分期。

Positive lymph node retrieval ratio optimises patient staging in colorectal cancer.

作者信息

Moug S J, Saldanha J D, McGregor J R, Balsitis M, Diament R H

机构信息

Department of General Surgery, Crosshouse Hospital, Kilmarnock, Scotland, UK.

出版信息

Br J Cancer. 2009 May 19;100(10):1530-3. doi: 10.1038/sj.bjc.6605049. Epub 2009 Apr 28.

Abstract

Alternative lymph node (LN) parameters have been proposed to improve staging in colorectal cancer. This study compared these alternative parameters with conventional TNM staging in predicting long-term survival in patients undergoing curative resection. A total of 295 consecutive patients (mean age 70 years; range 39-95; s.d. 10.4) underwent resection for colorectal cancer from 2001 to 2004. Age, sex, primary tumour site, TNM stage and chemotherapy/radiotherapy were recorded. Patients with colon and rectal cancers were analysed separately for LN parameters: LN total; adequate LN retrieval (> or =12) and inadequate (<12); total number of negative LN; total number of positive LN and the ratio of positive LN to total LN (pLNR). Univariate and multivariate survival analysis was performed. The median number of LN retrieved was 10 (1-57) with adequate LN retrieval in 147 cases (49.8%). For each T and N stage, inadequate LN retrieval did not adversely affect long-term survival (P>0.05). On multivariate analysis, only pLNR was an independent predictor of overall survival in both colon and rectal cancers (HR 11.65, 95% CI 5.00-27.15, P<0.001 and HR 13.40, 95% CI 3.64-49.10, P<0.001, respectively). Application of pLNR subdivided patients into four prognostic groups. Application of the pLNR improved patient stratification in colorectal cancer and should be considered in future staging systems.

摘要

有人提出了替代淋巴结(LN)参数以改善结直肠癌的分期。本研究比较了这些替代参数与传统TNM分期在预测接受根治性切除患者的长期生存方面的情况。2001年至2004年期间,共有295例连续的患者(平均年龄70岁;范围39 - 95岁;标准差10.4)接受了结直肠癌切除术。记录了年龄、性别、原发肿瘤部位、TNM分期以及化疗/放疗情况。对结肠癌和直肠癌患者分别分析LN参数:LN总数;足够的LN检出数(≥12个)和不足的(<12个);阴性LN总数;阳性LN总数以及阳性LN与总LN的比例(pLNR)。进行了单因素和多因素生存分析。LN检出的中位数为10个(1 - 57个),147例(49.8%)患者的LN检出足够。对于每个T和N分期,LN检出不足并未对长期生存产生不利影响(P>0.05)。多因素分析显示,仅pLNR是结肠癌和直肠癌总体生存的独立预测因素(HR分别为11.65,95%CI 5.00 - 27.15,P<0.001和HR 13.40,95%CI 3.64 - 49.10,P<0.001)。应用pLNR可将患者分为四个预后组。pLNR的应用改善了结直肠癌患者的分层,应在未来的分期系统中予以考虑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/615c/2696755/805d498db661/6605049f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验